BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11854065)

  • 21. Implication of malignancy and prognosis of p27(kip1), Cyclin E, and Cdk2 expression in epithelial ovarian tumors.
    Sui L; Dong Y; Ohno M; Sugimoto K; Tai Y; Hando T; Tokuda M
    Gynecol Oncol; 2001 Oct; 83(1):56-63. PubMed ID: 11585414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing.
    Lee JJ; Kuo MY; Cheng SJ; Chiang CP; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Apr; 99(4):471-8. PubMed ID: 15772596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic role of p21WAF1 expression in areca quid chewing and smoking-associated oral squamous cell carcinoma in Taiwan.
    Yen-Ping Kuo M; Huang JS; Kok SH; Kuo YS; Chiang CP
    J Oral Pathol Med; 2002 Jan; 31(1):16-22. PubMed ID: 11896818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of p27(Kip1) and CyclinD1 expression in esophageal cancer.
    Itami A; Shimada Y; Watanabe G; Imamura M
    Oncology; 1999 Nov; 57(4):311-7. PubMed ID: 10575318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of p53 overexpression to other cell cycle regulatory proteins in oral squamous cell carcinoma.
    Warnakulasuriya KA; Tavassoli M; Johnson NW
    J Oral Pathol Med; 1998 Sep; 27(8):376-81. PubMed ID: 9736426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in epithelial ovarian cancer.
    Hurteau JA; Allison BM; Brutkiewicz SA; Goebl MG; Heilman DK; Bigsby RM; Harrington MA
    Gynecol Oncol; 2001 Nov; 83(2):292-8. PubMed ID: 11606087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic impact of cyclin dependent kinase inhibitors p21WAF1, p27Kip1, and p16INK4/MTS1 in adenocarcinomas of the uterine cervix: an immunohistochemical evaluation of expression patterns in population-based material from 142 patients with international federation of gynecology and obstetrics stage I and II adenocarcinoma.
    Alfsen GC; Reed W; Sandstad B; Kristensen GB; Abeler VM
    Cancer; 2003 Nov; 98(9):1880-9. PubMed ID: 14584070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of p53 protein correlates with decreased survival in patients with areca quid chewing and smoking-associated oral squamous cell carcinomas in Taiwan.
    Chiang CP; Huang JS; Wang JT; Liu BY; Kuo YS; Hahn LJ; Kuo MY
    J Oral Pathol Med; 1999 Feb; 28(2):72-6. PubMed ID: 9950253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p27 Expression, a cyclin dependent kinase inhibitor in breast carcinoma.
    Barbareschi M
    Adv Clin Path; 1999 Oct; 3(4):119-27. PubMed ID: 10936889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased p27(Kip1) expression and cyclin D1 overexpression, alone and in combination, influence recurrence and survival of patients with resectable extrahepatic bile duct carcinoma.
    Hui AM; Cui X; Makuuchi M; Li X; Shi YZ; Takayama T
    Hepatology; 1999 Nov; 30(5):1167-73. PubMed ID: 10534337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of p27(KIP1) and p21(WAF1/CIP1) in primary hepatocellular carcinoma: clinicopathologic correlation and survival analysis.
    Qin LF; Ng IO
    Hum Pathol; 2001 Aug; 32(8):778-84. PubMed ID: 11521219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p27/kip1 expression in normal epithelium, benign and neoplastic breast lesions.
    De Paola F; Vecci AM; Granato AM; Liverani M; Monti F; Innoceta AM; Gianni L; Saragoni L; Ricci M; Falcini F; Amadori D; Volpi A
    J Pathol; 2002 Jan; 196(1):26-31. PubMed ID: 11748638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer.
    Viglietto G; Motti ML; Bruni P; Melillo RM; D'Alessio A; Califano D; Vinci F; Chiappetta G; Tsichlis P; Bellacosa A; Fusco A; Santoro M
    Nat Med; 2002 Oct; 8(10):1136-44. PubMed ID: 12244303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas.
    Masciullo V; Susini T; Zamparelli A; Bovicelli A; Minimo C; Massi D; Taddei G; Maggiano N; De Iaco P; Ceccaroni M; Bovicelli L; Amunni G; Mancuso S; Scambia G; Giordano A
    Clin Cancer Res; 2003 Nov; 9(14):5332-8. PubMed ID: 14614018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
    Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
    Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low expression of p27(Kip1), a cyclin-dependent kinase inhibitor, is a marker of poor prognosis in synovial sarcoma.
    Kawauchi S; Goto Y; Liu XP; Furuya T; Oga A; Oda Y; Tsuneyoshi M; Ihara K; Sasaki K
    Cancer; 2001 Mar; 91(5):1005-12. PubMed ID: 11251953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced levels of the cell-cycle inhibitor p27Kip1 in epithelial dysplasia and carcinoma of the oral cavity.
    Jordan RC; Bradley G; Slingerland J
    Am J Pathol; 1998 Feb; 152(2):585-90. PubMed ID: 9466585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistent and heterogenous expression of the cyclin-dependent kinase inhibitor, p27KIP1, in rat hearts during development.
    Koh KN; Kang MJ; Frith-Terhune A; Park SK; Kim I; Lee CO; Koh GY
    J Mol Cell Cardiol; 1998 Mar; 30(3):463-74. PubMed ID: 9515024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low expression of p27(Kip1) in advanced mucoepidermoid carcinomas of head and neck.
    Choi CS; Choi G; Jung KY; Choi JO; Chae YS
    Head Neck; 2001 Apr; 23(4):292-7. PubMed ID: 11400230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MIB-1 (KI-67) proliferation index and cyclin-dependent kinase inhibitor p27(Kip1) protein expression in nephroblastoma.
    Ghanem MA; Van der Kwast TH; Sudaryo MK; Mathoera RB; van den Heuvel MM; Al-Doray AA; Nijman RM; van Steenbrugge GJ
    Clin Cancer Res; 2004 Jan; 10(2):591-7. PubMed ID: 14760081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.